West Pharmaceutical Services Current Ratio 2010-2025 | WST

Current and historical current ratio for West Pharmaceutical Services (WST) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. West Pharmaceutical Services current ratio for the three months ending March 31, 2025 was 2.77.
West Pharmaceutical Services Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $1.46B $0.53B 2.77
2024-12-31 $1.54B $0.55B 2.80
2024-09-30 $1.55B $0.52B 3.00
2024-06-30 $1.48B $0.63B 2.34
2024-03-31 $1.69B $0.65B 2.61
2023-12-31 $1.94B $0.67B 2.88
2023-09-30 $1.97B $0.53B 3.70
2023-06-30 $1.87B $0.51B 3.66
2023-03-31 $1.94B $0.54B 3.62
2022-12-31 $1.92B $0.52B 3.70
2022-09-30 $1.73B $0.46B 3.80
2022-06-30 $1.77B $0.57B 3.13
2022-03-31 $1.69B $0.59B 2.89
2021-12-31 $1.74B $0.59B 2.93
2021-09-30 $1.60B $0.56B 2.86
2021-06-30 $1.48B $0.47B 3.13
2021-03-31 $1.33B $0.48B 2.75
2020-12-31 $1.37B $0.50B 2.73
2020-09-30 $1.24B $0.45B 2.77
2020-06-30 $1.11B $0.38B 2.96
2020-03-31 $0.98B $0.34B 2.84
2019-12-31 $1.06B $0.34B 3.10
2019-09-30 $1.00B $0.34B 3.00
2019-06-30 $0.94B $0.31B 3.02
2019-03-31 $0.87B $0.30B 2.88
2018-12-31 $0.89B $0.28B 3.15
2018-09-30 $0.85B $0.29B 2.94
2018-06-30 $0.77B $0.29B 2.67
2018-03-31 $0.74B $0.26B 2.82
2017-12-31 $0.74B $0.28B 2.66
2017-09-30 $0.78B $0.30B 2.59
2017-06-30 $0.72B $0.29B 2.48
2017-03-31 $0.65B $0.26B 2.54
2016-12-31 $0.64B $0.24B 2.66
2016-09-30 $0.66B $0.24B 2.78
2016-06-30 $0.66B $0.24B 2.75
2016-03-31 $0.63B $0.24B 2.62
2015-12-31 $0.67B $0.31B 2.14
2015-09-30 $0.68B $0.30B 2.27
2015-06-30 $0.68B $0.31B 2.17
2015-03-31 $0.63B $0.30B 2.11
2014-12-31 $0.66B $0.25B 2.61
2014-09-30 $0.68B $0.24B 2.80
2014-06-30 $0.69B $0.22B 3.10
2014-03-31 $0.69B $0.23B 3.02
2013-12-31 $0.65B $0.24B 2.75
2013-09-30 $0.64B $0.25B 2.61
2013-06-30 $0.61B $0.22B 2.80
2013-03-31 $0.59B $0.21B 2.83
2012-12-31 $0.56B $0.26B 2.13
2012-09-30 $0.56B $0.28B 2.02
2012-06-30 $0.52B $0.32B 1.62
2012-03-31 $0.50B $0.30B 1.66
2011-12-31 $0.47B $0.24B 1.94
2011-09-30 $0.50B $0.23B 2.20
2011-06-30 $0.51B $0.19B 2.65
2011-03-31 $0.48B $0.18B 2.63
2010-12-31 $0.44B $0.17B 2.57
2010-09-30 $0.44B $0.16B 2.79
2010-06-30 $0.40B $0.16B 2.55
2010-03-31 $0.41B $0.18B 2.20
2009-12-31 $0.40B $0.17B 2.32
2009-09-30 $0.40B $0.16B 2.45
2009-06-30 $0.40B $0.16B 2.45
2009-03-31 $0.36B $0.14B 2.57
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.188B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.099B 21.51
Becton Dickinson (BDX) United States $52.271B 12.94
Cardinal Health (CAH) United States $37.565B 19.67
Straumann Holding AG (SAUHY) Switzerland $21.319B 0.00
Align Technology (ALGN) United States $14.918B 29.61
Cooper (COO) United States $14.739B 19.00
Henry Schein (HSIC) United States $8.526B 14.62
Merit Medical Systems (MMSI) United States $4.898B 23.68
DENTSPLY SIRONA (XRAY) United States $3.211B 9.59
CONMED (CNMD) United States $1.556B 11.64
STAAR Surgical (STAA) United States $0.920B 0.00
Pro-Dex (PDEX) United States $0.168B 18.40
Lifevantage (LFVN) United States $0.163B 16.77